Individualization of vancomycin therapy

Japanese Journal of Chemotherapy

Volumn 48, Issue 7, 2000, Pages 545-552

  Igarashi, M ^a   Nakatani, T ^a   Hayashi, M ^a   Nakata, K ^a   Kasuya, Y ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

TDM; Vancomycin

Indexed keywords

AMPICILLIN; BETAMIPRON; CEFEPIME; CEFOZOPRAN; CEFPIROME; CEFTAZIDIME; CILASTATIN; CLINDAMYCIN; FLUCONAZOLE; IMIPENEM; LATAMOXEF; MEROPENEM; PANIPENEM; PIPERACILLIN; SULBACTAM; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; HUMAN; MALE;

EID: 0033850376     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Vancomycin
2. Serum Vancomycin Concentrations: Reappraisal of Their Clinical Value
3. Vancomycin Therapy In patients with Impaired Renal Function
4. Clinical Pharmacokinetics of Vancomycin
5. Population Pharmacokinetics of Vancomycin in Japanese Adult Patients
6. Vancomycin
7. Analysis of Pharmacokinetic Data for Individualizing Drug Dosage Regimens
8. Prediction of Creatinine Clearance from Serum Creatine
9. Individualizing Vancomycin Dosage Regimens: One-Versus Two-Compartment Bayesian Models
10. A NONLINEAR MULTIPLE REGRESSION PROGRAM, MULTI 2 (BAYES), BASED ON BAYESIAN ALGORITHM FOR MICROCOMPUTERS
11. Pharmacokinetics of dosing regimens which utilise multiple intravenous infusions
12. Some suggestions for measuring predictive performance
13. Antimicrobial Treatment of Infective Endocarditis due to Viridans Streptococci, Enterococci, and Staphylococci
14. Staphylococcal Endocarditis, Laboratory and clinical basis for anitibiotic therapy
15. Glycopeptide tolerance in Staphylococcus aureus